Fort Washington Investment Advisors Inc Gilead Sciences, Inc. Transaction History
Fort Washington Investment Advisors Inc
- $16.8 Billion
- Q2 2025
A detailed history of Fort Washington Investment Advisors Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fort Washington Investment Advisors Inc holds 1,934 shares of GILD stock, worth $220,920. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,934
Previous 309,891
99.38%
Holding current value
$220,920
Previous $34.7 Million
99.38%
% of portfolio
0.0%
Previous 0.22%
Shares
31 transactions
Others Institutions Holding GILD
# of Institutions
2,296Shares Held
1BCall Options Held
9.6MPut Options Held
10.1M-
Black Rock Inc. New York, NY121MShares$13.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13.4 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.8 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.24 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.12 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $143B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...